Bridgefront Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,606
| Closed | -$149K | – | 618 |
|
|
2024
Q4 | $149K | Buy |
16,606
+1,891
| +13% | +$17K | 0.05% | 523 |
|
|
2024
Q3 | $108K | Buy |
+14,715
| New | +$108K | 0.04% | 491 |
|
|
2024
Q2 | – | Sell |
-10,279
| Closed | -$51.5K | – | 485 |
|
|
2024
Q1 | $51.5K | Buy |
+10,279
| New | +$51.5K | 0.04% | 355 |
|
|
2023
Q4 | – | Sell |
-12,812
| Closed | -$99.5K | – | 372 |
|
|
2023
Q3 | $99.5K | Buy |
+12,812
| New | +$99.5K | 0.07% | 360 |
|
|
2021
Q3 | – | Sell |
-11,040
| Closed | -$143K | – | 333 |
|
|
2021
Q2 | $143K | Buy |
+11,040
| New | +$143K | 0.05% | 536 |
|